Nuvectis Pharma Stock (NASDAQ:NVCT)
Previous Close
$7.73
52W Range
$4.44 - $11.80
50D Avg
$8.55
200D Avg
$7.56
Market Cap
$162.55M
Avg Vol (3M)
$171.32K
Beta
-0.26
Div Yield
-
NVCT Company Profile
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.